Research Site — Mesquite, Texas

Research Site is a clinical research site located in Mesquite, Texas, United States 75150.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 29 clinical trials with 10 currently active.

Therapeutic areas: Active Systemic Lupus Erythematosus, Rheumatoid Arthritis, Atherosclerotic Cardiovascular Disease.

Sponsors: AstraZeneca, Amgen, Fujifilm Kyowa Kirin Biologics Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mesquite

Browse all research sites in Texas · View every site in Mesquite

• SMS Clinical Research
• Southwest Rheumatology Research
• Southern Endocrinology Associates
• Novartis Investigative Site
• Texas Cancer Center of Mesquite
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Investigational Site Number 840074
• GSK Investigational Site
• Southern Endocrinology Associates PA
• Southwest Rheumatology

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 29 clinical trials on record, with 10 currently active. Their work covers Active Systemic Lupus Erythematosus, Rheumatoid Arthritis, Atherosclerotic Cardiovascular Disease.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.